Showing results (121-130 of 1,188) with videos related to
Sort By:
Pageof 119
BMC Pharmacology & Toxicology|October 25, 2025
Quality evaluation of cephalexin, cefuroxime, and ceftriaxone medicines marketed in Addis Ababa city, Ethiopia with three tier level approach and anti-microbial assaysWorku Birhane, Tigist Getachew, Molalegne Bitew, et al.BMC Pharmacology & Toxicology|August 5, 2025
Integrative genomic and bioinformatic prioritization of drug repurposing candidates for prostate cancerLalu Muhammad Irham, Wirawan Adikusuma, Arief Rahman Afief, et al.BMC Pharmacology & Toxicology|March 27, 2025
Mitigating hepatic ischemia and reperfusion injury with polyethylene glycol-enriched Ringer's lactate fluid: insights from an isolated perfused rat modelIkram Ben Jeddou, Mohamed Amine Zaouali, Roua Chaabani, et al.BMC Pharmacology & Toxicology|July 23, 2014
Is the standard dose of amoxicillin-clavulanic acid sufficient?Michiel Haeseker, Thomas Havenith, Leo Stolk, et al.BMC Pharmacology & Toxicology|July 23, 2014
A randomized, placebo-controlled trial to determine the course of aminotransferase elevation during prolonged acetaminophen administrationKennon Heard, Jody L Green, Victoria Anderson, et al.BMC Pharmacology & Toxicology|December 3, 2013
Indoxyl sulfate promotes apoptosis in cultured osteoblast cellsYoung-Hee Kim, Kyung-Ah Kwak, Hyo-Wook Gil, et al.BMC Pharmacology & Toxicology|April 5, 2013
Cotrimoxazole plasma levels, dialyzer clearance and total removal by extended dialysis in a patient with acute kidney injury: risk of under-dosing using current dosing recommendationsChristian Clajus, W Nikolaus Kühn-Velten, Julius J Schmidt, et al.BMC Pharmacology & Toxicology|March 19, 2013
Attitudes among healthcare professionals to the reporting of adverse drug reactions in NepalK C Santosh, Pramote Tragulpiankit, Sarun Gorsanan, et al.BMC Pharmacology & Toxicology|January 15, 2013
Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231Mariel Núñez, Vanina Medina, Graciela Cricco, et al.BMC Pharmacology & Toxicology|October 1, 2014
Open, single-blind, double-blind: which peer review process do you prefer?Elizabeth C Moylan, Simon Harold, Ciaran O'Neill, et al.Pageof 119